Your browser doesn't support javascript.
loading
Deletion of AMPK minimizes graft-versus-host disease through an early impact on effector donor T cells.
Monlish, Darlene A; Beezhold, Kevin J; Chiaranunt, Pailin; Paz, Katelyn; Moore, Nathan J; Dobbs, Andrea K; Brown, Rebecca A; Ozolek, John A; Blazar, Bruce R; Byersdorfer, Craig A.
Afiliación
  • Monlish DA; Division of Blood and Marrow Transplantation and Cellular Therapies, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Beezhold KJ; Division of Blood and Marrow Transplantation and Cellular Therapies, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Chiaranunt P; Division of Blood and Marrow Transplantation and Cellular Therapies, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Paz K; Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA.
  • Moore NJ; Division of Blood and Marrow Transplantation and Cellular Therapies, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Dobbs AK; Division of Blood and Marrow Transplantation and Cellular Therapies, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Brown RA; Division of Blood and Marrow Transplantation and Cellular Therapies, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Ozolek JA; Department of Pathology, Anatomy and Laboratory Medicine, School of Medicine, West Virginia University, Morgantown, West Virginia, USA.
  • Blazar BR; Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA.
  • Byersdorfer CA; Division of Blood and Marrow Transplantation and Cellular Therapies, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
JCI Insight ; 6(14)2021 07 22.
Article en En | MEDLINE | ID: mdl-34291733
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T Reguladores / Trasplante de Células Madre Hematopoyéticas / Proteínas Quinasas Activadas por AMP / Enfermedad Injerto contra Huésped Límite: Animals / Female / Humans / Male Idioma: En Revista: JCI Insight Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T Reguladores / Trasplante de Células Madre Hematopoyéticas / Proteínas Quinasas Activadas por AMP / Enfermedad Injerto contra Huésped Límite: Animals / Female / Humans / Male Idioma: En Revista: JCI Insight Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos